Don B. Rix
Nessuna posizione attualmente
Storia della carriera di Don B. Rix
Precedenti posizioni note di Don B. Rix
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lions Capital Corp.
Lions Capital Corp. Investment ManagersFinance Lions Capital Corp (Lions Capital) is a fund management and corporate advisory firm founded in 2003. The firm headquartered in Vancouver, Canada. | Presidente | - | 30/06/2010 |
Yaletown Venture Partners, Inc.
Yaletown Venture Partners, Inc. Investment ManagersFinance Yaletown Venture Partners, Inc (Yaletown Partners) is a venture capital firm founded in 2001 by Mike Satterfield and Hans Knapp. The firm is headquartered in Vancouver, British Columbia. | Corporate Officer/Principal | - | 31/12/2009 |
BC Children's Hospital Foundation | Direttore/Membro del Consiglio | 06/11/2009 | 06/11/2009 |
Premier's Technology Council | Direttore/Membro del Consiglio | 06/11/2009 | 06/11/2009 |
Rix Venture Capital (VCC) Corp.
Rix Venture Capital (VCC) Corp. MiscellaneousMiscellaneous Founded by Donald B. Rix, Rix Venture Capital (VCC) Corp. is a venture capital firm located in Vancouver, British Columbia, Canada | Presidente | 24/03/2009 | 24/03/2009 |
Direttore degli Investimenti | - | 06/11/2009 | |
Investitore di Private Equity | - | 25/06/2010 | |
Corporate Officer/Principal | - | 06/11/2009 | |
LifeLabs, Inc.
LifeLabs, Inc. Miscellaneous Commercial ServicesCommercial Services LifeLabs, Inc. provides laboratory testing services. It provides specialized clinical laboratory testing, hospital laboratory services, occupational health services, clinical studies services, online kit ordering services. The firm helps physicians and other healthcare providers in prevention, diagnosis, treatment and monitoring of disease and illness in patients. The company was founded in 1969 and is headquartered in Toronto, ON. | Presidente | 01/01/1994 | 06/11/2009 |
SOPHIRIS BIO | Direttore/Membro del Consiglio | 23/06/2008 | 23/06/2008 |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Direttore/Membro del Consiglio | 17/05/2007 | 27/05/2008 |
PROMIS NEUROSCIENCES, INC. | Direttore/Membro del Consiglio | - | 16/06/2006 |
░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░░░ | ░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░ ░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
Formazione di Don B. Rix
University of Western Ontario | Doctorate Degree |
Statistiche
Distribuzione geografica
Canada | 16 |
Stati Uniti | 4 |
Posizioni
Director/Board Member | 9 |
Chairman | 9 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 5 |
Commercial Services | 5 |
Finance | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
RESVERLOGIX CORP. | Health Technology |
QUEST PHARMATECH INC. | Commercial Services |
PROMIS NEUROSCIENCES, INC. | Health Technology |
Aziende private | 14 |
---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
BC Advantage Funds Ltd.
BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Finance |
Perceptronix Medical, Inc.
Perceptronix Medical, Inc. Medical/Nursing ServicesHealth Services Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada. | Health Services |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Finance |
Yaletown Venture Partners, Inc.
Yaletown Venture Partners, Inc. Investment ManagersFinance Yaletown Venture Partners, Inc (Yaletown Partners) is a venture capital firm founded in 2001 by Mike Satterfield and Hans Knapp. The firm is headquartered in Vancouver, British Columbia. | Finance |
CANTEST Ltd.
CANTEST Ltd. Miscellaneous Commercial ServicesCommercial Services CANTEST Ltd. provides analytical testing and consultation services to government and individuals in environmental, biotechnology, pharmaceutical, food safety, and industrial hygiene related fields. It operates services in British Columbia, Manitoba, Ontario, Canada, United States, and Southeast Asia. The company was founded in 1969 and is located in Burnaby, Canada | Commercial Services |
LifeLabs, Inc.
LifeLabs, Inc. Miscellaneous Commercial ServicesCommercial Services LifeLabs, Inc. provides laboratory testing services. It provides specialized clinical laboratory testing, hospital laboratory services, occupational health services, clinical studies services, online kit ordering services. The firm helps physicians and other healthcare providers in prevention, diagnosis, treatment and monitoring of disease and illness in patients. The company was founded in 1969 and is headquartered in Toronto, ON. | Commercial Services |
Innovate BC
Innovate BC Miscellaneous Commercial ServicesCommercial Services Innovate BC develops entrepreneurial talent and supports commercializing technology. The firm focuses on competitively positioning British Columbia in today's global knowledge economy in order to provide significant employment opportunities and a high standard of living for British Columbians. The company was founded in 1978 and is headquartered in Vancouver, Canada. | Commercial Services |
Lions Capital Corp.
Lions Capital Corp. Investment ManagersFinance Lions Capital Corp (Lions Capital) is a fund management and corporate advisory firm founded in 2003. The firm headquartered in Vancouver, Canada. | Finance |
Premier's Technology Council | Government |
BC Children's Hospital Foundation | Miscellaneous |
PrioNet Canada
PrioNet Canada PrioNet Canada developed strategies to eradicate prion diseases such as mad cow and Creutzfeldt - Jakob disease. The company was headquartered in Vancouver, Canada. | |
Rix Venture Capital (VCC) Corp.
Rix Venture Capital (VCC) Corp. MiscellaneousMiscellaneous Founded by Donald B. Rix, Rix Venture Capital (VCC) Corp. is a venture capital firm located in Vancouver, British Columbia, Canada | Miscellaneous |
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Don B. Rix
- Esperienza